vs
Side-by-side financial comparison of Fidelity National Financial, Inc. (FNF) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Fidelity National Financial, Inc. is the larger business by last-quarter revenue ($544.0M vs $493.8M, roughly 1.1× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -21.5%, a 28.3% gap on every dollar of revenue. On growth, Fidelity National Financial, Inc. posted the faster year-over-year revenue change (10.3% vs -1.7%). Over the past eight quarters, Fidelity National Financial, Inc.'s revenue compounded faster (13.7% CAGR vs -0.1%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FNF vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $544.0M | $493.8M |
| Net Profit | $-117.0M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 82.9% | 9.9% |
| Net Margin | -21.5% | 6.8% |
| Revenue YoY | 10.3% | -1.7% |
| Net Profit YoY | -126.0% | 10.5% |
| EPS (diluted) | $-0.44 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $544.0M | $493.8M | ||
| Q3 25 | $553.0M | $492.9M | ||
| Q2 25 | $547.0M | $468.8M | ||
| Q1 25 | $455.0M | $458.4M | ||
| Q4 24 | $493.0M | $502.4M | ||
| Q3 24 | $506.0M | $511.2M | ||
| Q2 24 | $504.0M | $504.3M | ||
| Q1 24 | $421.0M | $495.1M |
| Q4 25 | $-117.0M | $33.7M | ||
| Q3 25 | $358.0M | $71.7M | ||
| Q2 25 | $278.0M | $39.3M | ||
| Q1 25 | $83.0M | $20.7M | ||
| Q4 24 | $450.0M | $30.5M | ||
| Q3 24 | $266.0M | $19.4M | ||
| Q2 24 | $306.0M | $-153.0M | ||
| Q1 24 | $248.0M | $4.0M |
| Q4 25 | 82.9% | 9.9% | ||
| Q3 25 | 81.9% | 13.8% | ||
| Q2 25 | 69.8% | 12.8% | ||
| Q1 25 | 24.4% | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | 61.9% | 6.6% | ||
| Q2 24 | 90.9% | -31.3% | ||
| Q1 24 | 78.6% | 3.2% |
| Q4 25 | -21.5% | 6.8% | ||
| Q3 25 | 64.7% | 14.5% | ||
| Q2 25 | 50.8% | 8.4% | ||
| Q1 25 | 18.2% | 4.5% | ||
| Q4 24 | 91.3% | 6.1% | ||
| Q3 24 | 52.6% | 3.8% | ||
| Q2 24 | 60.7% | -30.3% | ||
| Q1 24 | 58.9% | 0.8% |
| Q4 25 | $-0.44 | $0.40 | ||
| Q3 25 | $1.33 | $0.84 | ||
| Q2 25 | $1.02 | $0.46 | ||
| Q1 25 | $0.30 | $0.24 | ||
| Q4 24 | $1.65 | $0.37 | ||
| Q3 24 | $0.97 | $0.23 | ||
| Q2 24 | $1.12 | $-1.84 | ||
| Q1 24 | $0.91 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6B | $375.2M |
| Total DebtLower is stronger | $4.4B | $570.5M |
| Stockholders' EquityBook value | $7.4B | $865.9M |
| Total Assets | $109.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.59× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.6B | $375.2M | ||
| Q3 25 | $3.5B | $340.1M | ||
| Q2 25 | $3.3B | $224.7M | ||
| Q1 25 | $4.5B | $99.0M | ||
| Q4 24 | $3.5B | $229.9M | ||
| Q3 24 | $5.0B | $103.8M | ||
| Q2 24 | $4.9B | $19.4M | ||
| Q1 24 | $3.5B | $8.0M |
| Q4 25 | $4.4B | $570.5M | ||
| Q3 25 | $4.4B | $577.2M | ||
| Q2 25 | $4.4B | $583.9M | ||
| Q1 25 | $4.4B | $590.5M | ||
| Q4 24 | $4.3B | $597.1M | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $4.2B | — | ||
| Q1 24 | $3.9B | — |
| Q4 25 | $7.4B | $865.9M | ||
| Q3 25 | $8.4B | $890.7M | ||
| Q2 25 | $7.9B | $833.8M | ||
| Q1 25 | $7.9B | $789.2M | ||
| Q4 24 | $7.8B | $764.9M | ||
| Q3 24 | $8.1B | $732.5M | ||
| Q2 24 | $7.3B | $706.5M | ||
| Q1 24 | $7.1B | $856.2M |
| Q4 25 | $109.0B | $2.2B | ||
| Q3 25 | $106.6B | $2.2B | ||
| Q2 25 | $102.3B | $2.1B | ||
| Q1 25 | $98.2B | $2.0B | ||
| Q4 24 | $95.4B | $2.2B | ||
| Q3 24 | $94.7B | $2.1B | ||
| Q2 24 | $88.8B | $2.0B | ||
| Q1 24 | $84.5B | $2.2B |
| Q4 25 | 0.59× | 0.66× | ||
| Q3 25 | 0.53× | 0.65× | ||
| Q2 25 | 0.56× | 0.70× | ||
| Q1 25 | 0.56× | 0.75× | ||
| Q4 24 | 0.56× | 0.78× | ||
| Q3 24 | 0.52× | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 0.55× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5B | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5B | $114.1M | ||
| Q3 25 | $1.3B | $137.3M | ||
| Q2 25 | $1.9B | $137.2M | ||
| Q1 25 | $1.1B | $-117.5M | ||
| Q4 24 | $1.5B | $133.0M | ||
| Q3 24 | $2.4B | $91.8M | ||
| Q2 24 | $1.4B | $107.0M | ||
| Q1 24 | $1.6B | $-125.2M |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 3.66× | 1.91× | ||
| Q2 25 | 6.82× | 3.49× | ||
| Q1 25 | 13.43× | -5.66× | ||
| Q4 24 | 3.32× | 4.36× | ||
| Q3 24 | 8.89× | 4.72× | ||
| Q2 24 | 4.45× | — | ||
| Q1 24 | 6.42× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FNF
| Escrow Fees | $241.0M | 44% |
| Other Title Related Fees And Income | $182.0M | 33% |
| Service Link Excluding Title Premiums Escrow Fees And Subservicing Fees | $87.0M | 16% |
| Insurance Contracts Home Warranty | $31.0M | 6% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
